The COVID-19 pandemic has negatively affected the ability of ophthalmologists to care for patients, with ambulatory outpatient visits declining by 79% during the height of the pandemic.
1 By the end of 2020, the volume of outpatient visits was 18% less than expected.
2 Telemedicine became mandatory in many clinical settings as an alternative model of care for patient evaluation while maintaining strict social distancing standards and decreasing the risk of viral transmission.
3 Regulatory changes implemented at the outset of the pandemic, such as payment equivalency for telemedicine and in-person visits as well as the loosening of Health Insurance Portability and Accountability Act compliance standards for virtual visit platforms, all supported the use of telemedicine during the pandemic.
4,5 Some ophthalmologists rapidly implemented telemedicine at the outset of the pandemic to maintain patient care. One study
3 showed the proportion of ophthalmic visits using telemedicine peaking at 17% in early April 2020, whereas telemedicine represented only 0.04% of all ophthalmic visits in the preceding 6 months.